Epicondylar Muscle Activation in Tennis Players

NCT ID: NCT06160011

Last Updated: 2024-12-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-01

Study Completion Date

2024-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Epicondylitis is one of the most common pathologies in tennis players. The search for an effective treatment is necessary for the relief of symptoms and the return to sports practice. Therefore, a ddry needling treatment in combination with electricity is postulated as an alternative to isolated dry needling treatment or conventional physiotherapy treatment. Data will be collected in relation to pain and muscle activation by EMG in order to check the effectiveness of these techniques as well as the muscle activation that is generated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epicondylitis, Lateral

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Electrical dry needling EMG Tennis Physiotherapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group Electrical Dry Needling amd Physiotherapy

The intervention group will receive a treatment composed by electrical dry needling and conventional physiotherapy treatment

Group Type EXPERIMENTAL

Electrical dry needling + Conventional physiotherapy

Intervention Type OTHER

Electrical dry needling and conventional physiotherapy treatment (massage, pressure release): 2 sessions

Intervention Group Dry Needling amd Physiotherapy

This group will receive a treatment composed by dry needling and conventional physiotherapy treatment

Group Type ACTIVE_COMPARATOR

Dry needling + Conventional physiotherapy

Intervention Type OTHER

Dry needling and conventional physiotherapy treatment (massage, pressure release): 2 sessions

Control Group

Control group will receive conventional physiotherapy treatment

Group Type PLACEBO_COMPARATOR

Conventional physiotherapy

Intervention Type OTHER

Conventional physiotherapy treatment (massage, pressure release): 2 sessions

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electrical dry needling + Conventional physiotherapy

Electrical dry needling and conventional physiotherapy treatment (massage, pressure release): 2 sessions

Intervention Type OTHER

Dry needling + Conventional physiotherapy

Dry needling and conventional physiotherapy treatment (massage, pressure release): 2 sessions

Intervention Type OTHER

Conventional physiotherapy

Conventional physiotherapy treatment (massage, pressure release): 2 sessions

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* tennis players of both sexes
* federated and non-federated of Castilla y León
* playing tennis for at least 2 years
* presence if one trigger point in epicondilar musculature

Exclusion Criteria

* not informed consent signature
* nervous, vascular, articular or musculoskeletal system alterations
* tests or techniques performed fear (belonephobia)
* pregnancy
* allergic to any type of metal or body oil
* active febrile proces
* current pain treatments in the area involved
* surgery in the last year for upper limb pathologies
* cognitive alterations
* taking painkillers or anti-inflammatory drugs 24 hours before the start of the study or taking them during the duration of the study
Minimum Eligible Age

16 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Salamanca

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rocío Llamas-Ramos

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universidad de Salamanca

Salamanca, Salamanca, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EMGepicondíleos

Identifier Type: -

Identifier Source: org_study_id